Cutaneous T-Cell Lymphoma (CTLC)
Showing 9951 - 9975 of >10,000
Osteoarthritis Trial in United States (Bone Marrow Derived MSCs, Adipose-derived MSCs, Umbilical Cord Tissue (UCT) MSCs)
Completed
- Osteoarthritis
- Bone Marrow Derived MSCs
- +3 more
-
Gulf Breeze, Florida
- +4 more
Jul 5, 2022
Acute Lymphoblastic Leukemia, Pediatric Trial in Giza (Balance exrcises, Balance exrcises and Treadmill training)
Completed
- Acute Lymphoblastic Leukemia, Pediatric
- Balance exrcises
- Balance exrcises and Treadmill training
-
Giza, Cairo, Egypt
- +1 more
Nov 12, 2021
Premature Ovarian Failure Trial in Zhengzhou (hucMSCs)
Suspended
- Premature Ovarian Failure
- hucMSCs
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jan 29, 2022
Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease Trial in Bruxelles (Clonidine)
Recruiting
- Sickle Cell Disease
- Vaso-occlusive Pain Episode in Sickle Cell Disease
-
Bruxelles, BelgiumCHU Saint-Pierre
May 5, 2023
Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Penile Cancer
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 16, 2022
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle
Not yet recruiting
- Post-Transplant Lymphoproliferative Disorder
- +10 more
- Loncastuximab Tesirine
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2022
Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland
Not yet recruiting
- Locally Advanced Thyroid Gland Anaplastic Carcinoma
- +2 more
-
Chicago, Illinois
- +1 more
Jul 7, 2022
NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- bexmarilimab (FP-1305)
- Pembrolizumab
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
May 13, 2022
Lung Cancer Trial in Izmir (hand-held fan airflow stimulation)
Enrolling by invitation
- Lung Cancer
- hand-held fan airflow stimulation
-
Izmir, TurkeyIzmir Provincial Health Directorate Health Sciences University D
May 24, 2023
Neoadjuvant Therapy Trial in Nanning (tislelizumab combined with axitinib)
Active, not recruiting
- Neoadjuvant Therapy
- tislelizumab combined with axitinib
-
Nanning, Jiangsu, ChinaHongqian Guo
Dec 13, 2021
Ankle Osteoarthritis Trial in Astana (Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic
Recruiting
- Ankle Osteoarthritis
- Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic control
- Microfracture of ankle's cartilage lesion under arthroscopic control
-
Astana, KazakhstanCenter of National Scientific center Of Traumatology and Orthope
Aug 31, 2023
Chromosomal Instability in Early Diagnosis of Biliary Tract
Recruiting
- Biliary Tract Carcinoma
- The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
-
Taizhou, Zhejiang, ChinaTaizhou Hospital of Zhejiang Province
Apr 25, 2023
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,
Terminated
- Hematological Malignancies
- +3 more
- Mycophenolate Mofetil (MMF)
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 1, 2020
Patients With Cancer Undergoing Radiation Therapy
Terminated
- Malignant Neoplasm
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Aug 15, 2022
Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)
Recruiting
- Oncology
- +2 more
- UV1
- +2 more
-
Drammen, Viken, NorwayVestre Viken Health Trust
Aug 15, 2022
Cushing's Disease Trial run by the NINDS (Vorinostat)
Recruiting
- Cushing's Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Recruiting
- Bronchial Cancer
-
Strasbourg, FranceService de chirurgie thoracique - CHU de Strasbourg - France
Oct 28, 2022
Having a Blood Draw Trial (Stress Ball)
Not yet recruiting
- Having a Blood Draw
- Stress Ball
- (no location specified)
Feb 10, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
Asprosin in Periodontitis and Acute Coronary Syndrome
Recruiting
- Cardiovascular Diseases
- Periodontal Diseases
- Serum samples will be collected. Asprosin levels will be determined by biochemical analysis
-
Erzurum, TurkeyAtatürk University Faculty of Dentistry
Dec 13, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)
Withdrawn
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- enoblituzumab
- +2 more
- (no location specified)
Feb 4, 2022
Sickle Cell Disease Trial (Voxelotor Oral Tablet, Placebo)
Not yet recruiting
- Sickle Cell Disease
- Voxelotor Oral Tablet
- Placebo
- (no location specified)
Jan 27, 2022